These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 38774880)

  • 1. The role and therapeutic potential of macrophages in the pathogenesis of diabetic cardiomyopathy.
    Zhang S; Zhu X; Chen Y; Wen Z; Shi P; Ni Q
    Front Immunol; 2024; 15():1393392. PubMed ID: 38774880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The latest emerging drugs for the treatment of diabetic cardiomyopathy.
    Li M; Liu L; Zhang C; Deng L; Zhong Y; Liao B; Li X; Wan Y; Feng J
    Expert Opin Pharmacother; 2024 Apr; 25(6):641-654. PubMed ID: 38660817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting autophagy in diabetic cardiomyopathy: From molecular mechanisms to pharmacotherapy.
    Li J; Xie Y; Zheng S; He H; Wang Z; Li X; Jiao S; Liu D; Yang F; Zhao H; Li P; Sun Y
    Biomed Pharmacother; 2024 Jun; 175():116790. PubMed ID: 38776677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies targeting mechanisms of macrophages in diabetic heart disease.
    Zhang C; Shi Y; Liu C; Sudesh SM; Hu Z; Li P; Liu Q; Ma Y; Shi A; Cai H
    Cardiovasc Diabetol; 2024 May; 23(1):169. PubMed ID: 38750502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of exosomes and exosomal microRNA in diabetic cardiomyopathy.
    Gao S; Dong Y; Yan C; Yu T; Cao H
    Front Endocrinol (Lausanne); 2023; 14():1327495. PubMed ID: 38283742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell insights: pioneering an integrated atlas of chromatin accessibility and transcriptomic landscapes in diabetic cardiomyopathy.
    Su Q; Huang W; Huang Y; Dai R; Chang C; Li QY; Liu H; Li Z; Zhao Y; Wu Q; Pan DG
    Cardiovasc Diabetol; 2024 Apr; 23(1):139. PubMed ID: 38664790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy.
    Ke X; Lin Z; Ye Z; Leng M; Chen B; Jiang C; Jiang X; Li G
    Front Endocrinol (Lausanne); 2021; 12():679655. PubMed ID: 34367065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of inflammation and anti-inflammatory modalities on diabetic cardiomyopathy healing: From fundamental research to therapy.
    Zhang XJ; Han XW; Jiang YH; Wang YL; He XL; Liu DH; Huang J; Liu HH; Ye TC; Li SJ; Li ZR; Dong XM; Wu HY; Long WJ; Ni SH; Lu L; Yang ZQ
    Int Immunopharmacol; 2023 Oct; 123():110747. PubMed ID: 37586299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
    Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
    Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy.
    Dhar A; Venkadakrishnan J; Roy U; Vedam S; Lalwani N; Ramos KS; Pandita TK; Bhat A
    Ther Adv Cardiovasc Dis; 2023; 17():17539447231210170. PubMed ID: 38069578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway.
    Li X; Li Z; Li B; Zhu X; Lai X
    Life Sci; 2019 Oct; 234():116773. PubMed ID: 31422095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological Functions and Clinical Prospects of Extracellular Non-Coding RNAs in Diabetic Cardiomyopathy: an Updated Review.
    Yin Z; Chen C
    J Cardiovasc Transl Res; 2022 Jun; 15(3):469-476. PubMed ID: 35175553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiny molecule, big power: Multi-target approach for curcumin in diabetic cardiomyopathy.
    Karuppagounder V; Arumugam S; Giridharan VV; Sreedhar R; Bose RJ; Vanama J; Palaniyandi SS; Konishi T; Watanabe K; Thandavarayan RA
    Nutrition; 2017 Feb; 34():47-54. PubMed ID: 28063511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of liraglutide on microcirculation in experimental diabetic cardiomyopathy.
    Abdelrazik Soliman NG; Abdel-Hamid AAM; El-Hawwary AA; Ellakkany A
    Acta Histochem; 2020 Apr; 122(3):151533. PubMed ID: 32197755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway.
    Gbr AA; Abdel Baky NA; Mohamed EA; Zaky HS
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):349-360. PubMed ID: 32984914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy.
    Jin L; Deng Z; Zhang J; Yang C; Liu J; Han W; Ye P; Si Y; Chen G
    J Transl Med; 2019 Aug; 17(1):251. PubMed ID: 31382970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus.
    Graczyk P; Dach A; Dyrka K; Pawlik A
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic cardiomyopathy: where we are and where we are going.
    Lee WS; Kim J
    Korean J Intern Med; 2017 May; 32(3):404-421. PubMed ID: 28415836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Dysfunction in Diabetic Cardiomyopathy: The Possible Therapeutic Roles of Phenolic Acids.
    Jubaidi FF; Zainalabidin S; Mariappan V; Budin SB
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of pyroptosis in diabetic cardiomyopathy: an updated review.
    Wang G; Ma TY; Huang K; Zhong JH; Lu SJ; Li JJ
    Front Endocrinol (Lausanne); 2023; 14():1322907. PubMed ID: 38250736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.